These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 19875476)
21. Loss of microRNA-200a expression correlates with tumor progression in breast cancer. Jang K; Ahn H; Sim J; Han H; Abdul R; Paik SS; Chung MS; Jang SJ Transl Res; 2014 Mar; 163(3):242-51. PubMed ID: 24280074 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1. Chen LL; Zhang ZJ; Yi ZB; Li JJ Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042 [TBL] [Abstract][Full Text] [Related]
23. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer. Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524 [TBL] [Abstract][Full Text] [Related]
24. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway. Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204 [TBL] [Abstract][Full Text] [Related]
25. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144 [TBL] [Abstract][Full Text] [Related]
26. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528 [TBL] [Abstract][Full Text] [Related]
27. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1. Xie F; Hosany S; Zhong S; Jiang Y; Zhang F; Lin L; Wang X; Gao S; Hu X PLoS One; 2017; 12(10):e0185565. PubMed ID: 29016617 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer. Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT. Li Y; Wang YW; Chen X; Ma RR; Guo XY; Liu HT; Jiang SJ; Wei JM; Gao P Clin Breast Cancer; 2020 Apr; 20(2):e113-e126. PubMed ID: 31899158 [TBL] [Abstract][Full Text] [Related]
31. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4. Hanieh H Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202 [TBL] [Abstract][Full Text] [Related]
32. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Ma L; Teruya-Feldstein J; Weinberg RA Nature; 2007 Oct; 449(7163):682-8. PubMed ID: 17898713 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells. Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891 [TBL] [Abstract][Full Text] [Related]
34. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2. Chen Y; Wu N; Liu L; Dong H; Liu X J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224 [TBL] [Abstract][Full Text] [Related]
35. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740 [TBL] [Abstract][Full Text] [Related]
36. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11. Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249 [TBL] [Abstract][Full Text] [Related]
37. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis. Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007 [TBL] [Abstract][Full Text] [Related]
38. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization. Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767 [TBL] [Abstract][Full Text] [Related]
39. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228 [TBL] [Abstract][Full Text] [Related]
40. miR-214 inhibits epithelial-mesenchymal transition of breast cancer cells via downregulation of RNF8. Min L; Liu C; Kuang J; Wu X; Zhu L Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):791-798. PubMed ID: 31294443 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]